Cost-Effectiveness of Infant Vaccination with 13-Valent Versus 10-Valent Pneumococcal Conjuvate Vaccine in Korea.

J Y Lee, D J Park
Author Information
  1. J Y Lee: Pfizer Pharmaceuticals Korea Ltd., Seoul, South Korea.
  2. D J Park: Pfizer Pharmaceuticals Korea Ltd., Seoul, South Korea.

Abstract

No abstract text available.

Word Cloud

Created with Highcharts 10.0.0Cost-EffectivenessInfantVaccination13-ValentVersus10-ValentPneumococcalConjuvateVaccineKorea

Similar Articles

Cited By